ChosenMed Technology

Private

BeijingHealthcare & Life Scienceshttps://chosenmedinfo.com/

Last Round

Series C

Extension

Oct 8, 2021

Total Funding Raised

$364.99M

Company Overview

ChosenMed Technology is a biotechnology company that provides precision oncology products and services, including genomic sequencing, tumor screening, and bioinformatics analysis.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

next-generation sequencingNGSprecision medicinemolecular diagnosticsgenetic testingbioinformaticscompanion diagnosticsoncology testinggenomic profilingcancer diagnosticsliquid biopsyclinical decision supportgenomic data analysisbiotech servicesclinical trial support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ChosenMed Technology Comps

Public and private peers based on sector, stage, and business model.

ChosenMed Technology comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ChosenMed Technology Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C Extension	Oct 8, 2021
Corporate Funding	Oct 19, 2020
Series B	Apr 20, 2020
Series A	Jan 6, 2020
Strategic	Nov 23, 2017

View all Funding Rounds

ChosenMed Technology Investors

Notable investors and investment history

ChosenMed Technology investors
Investor	Rounds
HighLight Capital	Series B
CCIC Capital	Corporate Funding
Mimir Capital	Series B
德同资本	Series B
China Resources Pharmaceutical Industry Investment Fund	Series A
Yijing Capital	Series C Extension
China Equity Group	Series A, Strategic

View all Investors

ChosenMed Technology Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ChosenMed Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ChosenMed Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing

Year Founded2017

Last FundingOct 8, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.